RxDoctor Payments DataLook up a doctor →

Joel Young, MD

Psychiatry · Rochester Hills, MINPI 1356325468

Payments from drug & device makers

$1,874,186in general payments, 2019–2025

Across 897 payments — averaging $2089.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tris Pharma Inc$577K
  • Janssen Research & Development, LLC$371K
  • Jazz Pharmaceuticals Inc.$163K
  • Ironshore Pharmaceuticals Inc.$143K
  • Supernus Pharmaceuticals, Inc.$142K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$119K
  • plus $360K from 25 others
$1,125,507in research payments, 2019–2025

Across 40 payments — averaging $28,138 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tris Pharma Inc$687K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$244K
  • Jazz Pharmaceuticals Inc.$123K
  • Arbor Pharmaceuticals, Inc.$48K
  • Purdue Pharma L.p.$13K
  • Adlon Therapeutics L.p.$6K
  • plus $4K from 1 others

What the payments were for

  • Consulting fees$85,0408%
  • Speaking & faculty fees$425,43238%
  • Grants$540,78148%
  • Travel & lodging$48,3954%
  • Food & beverage$15,9371%
  • Education$300%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,874,186 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$47,331
Medicare patients
91
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl103$129,584
AuvelityDextromethorphan Hbr/Bupropion27$40,688
RexultiBrexpiprazole11$16,278
VyvanseLisdexamfetamine Dimesylate38$15,359
Dyanavel XrAmphetamine15$6,214
Lisdexamfetamine Dimesylate19$4,961
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine47$2,039
Methylphenidate ErMethylphenidate Hcl30$1,739
Bupropion XlBupropion Hcl42$689
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine43$636
Duloxetine Hcl30$517
Sertraline Hcl27$491
Venlafaxine Hcl ErVenlafaxine Hcl27$447
Olanzapine11$403
Methylphenidate Hcl23$365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$60,221$129,584103 claims
Axsome Therapeutics, Inc.Auvelity$27,449$40,68827 claims
Otsuka America Pharmaceutical, Inc.Rexulti$29,198$16,27811 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$30,447$15,35938 claims
Tris Pharma IncDyanavel Xr$576,718$6,21415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →